Keith D. Eaton

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

Julie R. Brahmer, Scott S. Tykodi, Laura Q.M. Chow et al. · New England Journal of Medicine · 2012 · 7.9K citations · Full text

Neratinib, an Irreversible Pan-ErbB Receptor Tyrosine Kinase Inhibitor: Results of a Phase II Trial in Patients With Advanced Non–Small-Cell Lung Cancer

Lecia V. Sequist, Benjamin Besse, Thomas J. Lynch et al. · Journal of Clinical Oncology · 2010 · 420 citations · Full text

Phase II Study of Daily Sunitinib in FDG-PET–Positive, Iodine-Refractory Differentiated Thyroid Cancer and Metastatic Medullary Carcinoma of the Thyroid with Functional Imaging Correlation

Laurie L. Carr, David A. Mankoff, Bernardo Goulart et al. · Clinical Cancer Research · 2010 · 417 citations · Full text

Plasma Processing Conditions Substantially Influence Circulating microRNA Biomarker Levels

Heather H. Cheng, Hye Son Yi, Yeon-Ju Kim et al. · PLoS ONE · 2013 · 304 citations · Full text

Validation and Implementation of Targeted Capture and Sequencing for the Detection of Actionable Mutation, Copy Number Variation, and Gene Rearrangement in Clinical Cancer Specimens

Colin C. Pritchard, Stephen J. Salipante, Karen M. Koehler et al. · Journal of Molecular Diagnostics · 2013 · 276 citations · Full text